The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Open accessAbstract
An estimated 5% of human cancers are caused by human papillomavirus (HPV) infections, and most of these cancers are of the cervix. Two prophylactic HPV vaccines that target the two most oncogenic virus types, HPV16 and HPV18, are now commercially available. In controlled clinical trials, the vaccines proved to be effective at preventing incident anogenital infection and the associated neoplastic disease that is induced by these virus types. Here, we highlight the specific aspects of HPV biology and vaccine composition that are likely to contribute to the efficacy of these vaccines, and we discuss how these particular features might or might not be relevant for the development of effective vaccines against other sexually transmitted viruses such as HIV and herpes simplex virus (HSV).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Dürst, M., Gissmann, L., Ikenberg, H., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
Bernard, H.-U., Burk, R. D., Chen, Z., van Doorslaer, K., Hausen, H. Z., & de Villiers, E.-M. (2010) · Virology · doi:10.1016/j.virol.2010.02.002 · Cited by 1,669
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Amanna, I. J., Carlson, N. E., & Slifka, M. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066092 · Cited by 1,286
Mascola, J. R., Stiegler, G., VanCott, T. C., Katinger, H., Carpenter, C. B., Hanson, C. E., Beary, H., Hayes, D., Frankel, S. S., Birx, D. L., et al. (2000) · Nature Medicine · doi:10.1038/72318 · Cited by 1,250
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
Giuliano, A. R., Palefsky, J. M., Goldstone, S., Moreira, E. D., Penny, M. E., Aranda, C., Vardas, E., Moi, H., Jessen, H., Hillman, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0909537 · Cited by 1,146
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Self-citationHPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
Palefsky, J. M., Giuliano, A. R., Goldstone, S., Moreira, E. D., Aranda, C., Jessen, H., Hillman, R., Ferris, D., Coutlee, F., Stoler, M. H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010971 · Cited by 948
Human Papillomavirus–Associated Cancers — United States, 2008–2012
Viens, L. J., Henley, S. J., Watson, M., Markowitz, L. E., Thomas, C. C., Thompson, T. D., Razzaghi, H., & Saraiya, M. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6526a1 · Cited by 874
Doorbar, J. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.006 · Cited by 856
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
The cervical cancer epidemic that screening has prevented in the UK
Peto, J., Gilham, C., Fletcher, O., & Matthews, F. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16674-9 · Cited by 808
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Distribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Salazar, K. L., Zhou, H. S., Xu, J., Peterson, L. E., Schwartz, M. R., Mody, D. R., & Ge, Y. (2015) · Acta Cytologica · doi:10.1159/000442512 · Cited by 721
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., Skinner, S. R., Apter, D., Naud, P., Salmerón, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70286-8 · Cited by 704
Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., & Schlegel, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 668
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Self-citationBrown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O., Hernandez‐Avila, M., Wheeler, C. M., Perez, G., Koutsky, L. A., Tay, E. H., Garcia, P., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597307 · Cited by 627
Harro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Self-citationBrotherton, J. M., Fridman, M., May, C. L., Chappell, G., Saville, A. M., & Gertig, D. M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60551-5 · Cited by 598
Breitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., & Lowy, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 589
Self-citationKjaer, S. K., Frederiksen, K., Munk, C., & Iftner, T. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq356 · Cited by 579
Carter, J. J., Koutsky, L. A., Hughes, J. P., Lee, S. K., Kuypers, J., Kiviat, N., & Galloway, D. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315498 · Cited by 575
Muñoz, N., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp534 · Cited by 566
Garland, S. M., Steben, M., Sings, H. L., James, M., Lu, S., Railkar, R., Barr, E., Haupt, R. M., & Joura, E. A. (2009) · The Journal of Infectious Diseases · doi:10.1086/597071 · Cited by 532
The Perpetual Challenge of Infectious Diseases
Fauci, A. S., & Morens, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108296 · Cited by 517
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Belshe, R. B., Leone, P. A., Bernstein, D. I., Wald, A., Levin, M. J., Stapleton, J. T., Gorfinkel, I., Morrow, R. L. A., Ewell, M. G., Stokes-Riner, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103151 · Cited by 510
Wheeler, C. M., Castellsagué, X., Garland, S. M., Szarewski, A., Paavonen, J., Naud, P., Salmerón, J., Chow, S.-N., Apter, D., Kitchener, H., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70287-x · Cited by 507
Roberts, J. N., Buck, C. B., Thompson, C. D., Kines, R., Bernardo, M., Choyke, P. L., Lowy, D. R., & Schiller, J. T. (2007) · Nature Medicine · doi:10.1038/nm1598 · Cited by 503
Self-citationGIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Corey, L., Langenberg, A. G. M., Ashley, R., Sekulovich, R. E., Izu, A. E., Douglas, Jr., Handsfield, H. H., Warren, T., Marr, L., Tyring, S., et al. (1999) · JAMA · doi:10.1001/jama.282.4.331 · Cited by 490
Efficient Intracellular Assembly of Papillomaviral Vectors
Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.751-757.2004 · Cited by 489
Self-citationBlock, S. L., Nolan, T., Sattler, C., Barr, E., Giacoletti, K. E. D., Marchant, C. D., Castellsagué, X., Rusche, S. A., Lukac, S., Bryan, J. T., et al. (2006) · Pediatrics · doi:10.1542/peds.2006-0461 · Cited by 484
Phalipon, A., Cardona, A., Kraehenbuhl, J.-P., Edelman, L., Sansonetti, P. J., & Corthésy, B. (2002) · Immunity · doi:10.1016/s1074-7613(02)00341-2 · Cited by 426
Plummer, M., Schiffman, M., Castle, P. E., Maucort‐Boulch, D., Wheeler, C. M., & ALTS (Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesions Triage Study) Group (2007) · The Journal of Infectious Diseases · doi:10.1086/516784 · Cited by 426
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Rose, R. C., Bonnez, W., Reichman, R. C., & Garcea, R. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1936-1944.1993 · Cited by 381
Donovan, B., Franklin, N., Guy, R., Grulich, A. E., Regan, D. G., Ali, H., Wand, H., & Fairley, C. K. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70225-5 · Cited by 380
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Pastrana, D. V., Buck, C. B., Pang, Y.-Y. S., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Krüger Kjaer, S., Lowy, D. R., & Schiller, J. T. (2004) · Virology · doi:10.1016/j.virol.2003.12.027 · Cited by 357
Self-citationMechanisms that determine plasma cell lifespan and the duration of humoral immunity
Amanna, I. J., & Slifka, M. K. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00912.x · Cited by 343
Chaturvedi, A. K., Katki, H. A., Hildesheim, A., Rodríguez, A. C., Quint, W., Schiffman, M., Van Doorn, L.-J., Porras, C., Wacholder, S., Gonzalez, P., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq139 · Cited by 329
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis
Powers, K. A., Poole, C., Pettifor, A. E., & Cohen, M. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70156-7 · Cited by 328
Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., García, P., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0031 · Cited by 328
Kreimer, A. R., Rodriguez, A. C., Hildesheim, A., Herrero, R., Porras, C., Schiffman, M., González, P., Solomon, D., Jiménez, S., Schiller, J. T., et al. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr319 · Cited by 324
Self-citationOncogenic activities of human papillomaviruses
McLaughlin-Drubin, M. E., & Münger, K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.06.008 · Cited by 321
Joura, E. A., Garland, S. M., Paavonen, J., Ferris, D. G., Perez, G., Ault, K. A., Huh, W. K., Sings, H. L., James, M. K., Haupt, R. M., et al. (2012) · BMJ · doi:10.1136/bmj.e1401 · Cited by 316
Genome variation of human papillomavirus types: Phylogenetic and medical implications
Bernard, H., Calleja‐Macias, I. E., & Dunn, S. T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21655 · Cited by 312
Bomsel, M., Tudor, D., Drillet, A.-S., Alfsen, A., Ganor, Y., Roger, M.-G., Mouz, N., Amacker, M., Chalifour, A., Diomede, L., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.015 · Cited by 293
Kines, R. C., Thompson, C. D., Lowy, D. R., Schiller, J. T., & Day, P. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908502106 · Cited by 293
Self-citationLiaw, K., Hildesheim, A., Burk, R. D., Gravitt, P., Wacholder, S., Manos, M. M., Scott, D. R., Sherman, M. E., Kurman, R. J., Glass, A. G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317638 · Cited by 291
Roden, R. B., Greenstone, H. L., Kirnbauer, R., Booy, F. P., Jessie, J., Lowy, D. R., & Schiller, J. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5875-5883.1996 · Cited by 275
Self-citationImmunobiology of HPV and HPV vaccines
Stanley, M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.02.003 · Cited by 271
Lai, S. K., Hida, K., Shukair, S., Wang, Y.-Y., Figueiredo, A., Cone, R., Hope, T. J., & Hanes, J. (2009) · Journal of Virology · doi:10.1128/jvi.01899-08 · Cited by 251
Pedersen, C., Petaja, T., Strauss, G., Rumke, H. C., Poder, A., Richardus, J. H., Spiessens, B., Descamps, D., Hardt, K., Lehtinen, M., et al. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.02.015 · Cited by 241
Barr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Li, Z., Palaniyandi, S., Zeng, R., Tuo, W., Roopenian, D. C., & Zhu, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012861108 · Cited by 224
Nardelli-Haefliger, D., Wirthner, D., Schiller, J. T., Lowy, D. R., Hildesheim, A., Ponci, F., & De Grandi, P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg018 · Cited by 207
Self-citationThe influence of virus structure on antibody responses and virus serotype formation
Bachmann, M. F., & Zinkernagel, R. M. (1996) · Immunology Today · doi:10.1016/s0167-5699(96)10066-9 · Cited by 204
Iftner, A., Klug, S. J., Garbe, C., Blum, A., Stancu, A., Wilczynski, S. P., & Iftner, T. (2003) · PubMed · Cited by 198
Joura, E. A., Kjaer, S. K., Wheeler, C. M., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Perez, G., Brown, D. R., Koutsky, L. A., Tay, E. H., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.073 · Cited by 198
Trus, B. L., Roden, R. B. S., Greenstone, H. L., Vrhel, M., Schiller, J. T., & Booy, F. P. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb0597-413 · Cited by 195
Self-citationKreimer, A. R., González, P., Katki, H. A., Porras, C., Schiffman, M., Rodriguez, A. C., Solomon, D., Jiménez, S., Schiller, J. T., Lowy, D. R., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70213-3 · Cited by 194
Self-citationRoteli-Martins, C. M., Naud, P., De Borba, P., Teixeira, J. C., De Carvalho, N. S., Zahaf, T., Sanchez, N., Geeraerts, B., & Descamps, D. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.18865 · Cited by 192
Human Papillomavirus–Associated Cancers—United States, 2004–2008
(2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04188.x · Cited by 192
HIV infection of the genital mucosa in women
Hladik, F., & Hope, T. J. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0004-1 · Cited by 184
Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles
Chackerian, B., Lenz, P., Lowy, D. R., & Schiller, J. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6120 · Cited by 181
Self-citationChan, S. Y., Ho, L., Ong, C. K., Chow, V, Drescher, B., Dürst, M., ter Meulen, J., Villa, L., Luande, J., & Mgaya, H. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2057-2066.1992 · Cited by 178
Herrero, R., Wacholder, S., Rodríguez, A. C., Solomon, D., González, P., Kreimer, A. R., Porras, C., Schussler, J., Jiménez, S., Sherman, M. E., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0131 · Cited by 177
Self-citationIn Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
Day, P. M., Kines, R. C., Thompson, C. D., Jagu, S., Roden, R. B., Lowy, D. R., & Schiller, J. T. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.003 · Cited by 171
Self-citationHerpes simplex virus infects most cell types in vitro: clues to its success
Karasneh, G. A., & Shukla, D. (2011) · Virology Journal · doi:10.1186/1743-422x-8-481 · Cited by 165
Petäjä, T., Keränen, H., Karppa, T., Kawa, A., Lantela, S., Siitari‐Mattila, M., Levänen, H., Tocklin, T., Godeaux, O., Lehtinen, M., et al. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.10.002 · Cited by 153
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
Kemp, T. J., Hildesheim, A., Safaeian, M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.001 · Cited by 151
Lin, Y., Borenstein, L. A., Selvakumar, R., et al. (1992) · Virology · doi:10.1016/0042-6822(92)90463-y · Cited by 149
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
HSV-2: in pursuit of a vaccine
Johnston, C., Koelle, D. M., & Wald, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57148 · Cited by 137
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Fox, B., Scholar, S., Rosen, J., Chakhtoura, N. A., Lebacq, M., der Most, R. G. V., et al. (2011) · Human Vaccines · doi:10.4161/hv.7.12.18282 · Cited by 119
NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16
Pastrana, D. V., Vass, W. C., Lowy, D. R., & Schiller, J. T. (2001) · Virology · doi:10.1006/viro.2000.0702 · Cited by 110
Self-citationLonget, S., Schiller, J. T., Bobst, M., Jichlinski, P., & Nardelli‐Haefliger, D. (2011) · Journal of Virology · doi:10.1128/jvi.06093-11 · Cited by 108
Self-citationGenital Transmission of Human Papillomavirus in Recently Formed Heterosexual Couples
Burchell, A. N., Coutlée, F., Tellier, P., Hanley, J., & Franco, E. L. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir644 · Cited by 103
Developments in virus-like particle-based vaccines for infectious diseases and cancer
Buonaguro, L., Tagliamonte, M., Tornesello, M. L., & Buonaguro, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.135 · Cited by 85
Carter, J. J., Wipf, G. C., Madeleine, M. M., Schwartz, S. M., Koutsky, L. A., & Galloway, D. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.4664-4672.2006 · Cited by 75
Lenz, P., Lowy, D. R., & Schiller, J. T. (2005) · European Journal of Immunology · doi:10.1002/eji.200425547 · Cited by 61
Self-citationTobery, T. W., Smith, J. F., Kuklin, N. A., Skulsky, D., Ackerson, C., Huang, L., Chen, L., Cook, J. C., McClements, W. L., & Jansen, K. U. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00679-5 · Cited by 48
Awasthi, S., Lubinski, J. M., & Friedman, H. M. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.017 · Cited by 40
Hook, L. M., Huang, J., Jiang, M. H., Hodinka, R. L., & Friedman, H. M. (2008) · Journal of Virology · doi:10.1128/jvi.02599-07 · Cited by 39
Strategies for eliciting HIV-1 inhibitory antibodies
Tomaras, G. D., & Haynes, B. F. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d2d45 · Cited by 34
HIV vaccine development at the turn of the 21st century
Girard, M. P., & Plotkin, S. A. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834ddc96 · Cited by 32
Kaushic, C., Nazli, A., Ferreira, V. H., & Kafka, J. K. (2011) · Methods · doi:10.1016/j.ymeth.2011.09.022 · Cited by 25
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Human papillomavirus molecular biology and disease association
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1822 · Cited by 941
Turning the corner on therapeutic cancer vaccines
Hollingsworth, R. E., & Jansen, K. (2019) · npj Vaccines · doi:10.1038/s41541-019-0103-y · Cited by 689
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations
Tran, E., Robbins, P. F., & Rosenberg, S. A. (2017) · Nature Immunology · doi:10.1038/ni.3682 · Cited by 443
Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer
Schiffman, M., & Wentzensen, N. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1406 · Cited by 324
Metadata
- Authors
- Schiller, J. T., & Lowy, D. R.
- Venue
- Nature Reviews Microbiology
- Published
- 2012-09-10
- Volume
- 10
- Issue
- 10
- Pages
- 681-692
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1983330985
- Cited by
- 293
- References
- 101
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.